Gen-Probe makes bid on Innogenetics- Belgium

Gen-Probe said its offer for Innogenetics NV would create the biggest “stand-alone” molecular diagnostics company, with close to $500 million in annual sales, and open a beachhead in Europe for its clinical test products. Sales of molecular diagnostics in Europe are expected to rise 24 percent a year until 2011, double the rate of the U.S. market. > News > Business -- Gen-Probe makes bid on biotech in Belgium

No comments: